ORIGIN THERAPEUTICS
Origin Therapeutics focuses on companies with a management team and high growth potential.
ORIGIN THERAPEUTICS
Founded:
2019-01-01
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-07 | Clairvoyant Therapeutics | Origin Therapeutics investment in Seed Round - Clairvoyant Therapeutics | N/A |
More informations about "Origin Therapeutics"
CORPORATE PRESENTATION - originpsychedelics.com
ORIGIN THERAPEUTICS 15 Kyle Gould is a Co-Founder of Hyperion Capital Inc., a boutique advisory firm specializing in the Healthcare and Technology Sectors. ... Jonathan is a member in good standing of the Young Presidents Organization (YPO) andserves on the board of several …See details»
Origin Therapeutics - Crunchbase Investor Profile & Investments
Origin Therapeutics focuses on companies with a management team and high growth potential. Lists Featuring This Company. Edit Lists Featuring This Company Section. Canada Venture …See details»
Origin Therapeutics Closes $6.5 Million Private Placement to Fund …
Aug 12, 2021 Origin Therapeutics Holdings Inc. (CSE: ORIG Proposed) (the “Company” or “Origin Therapeutics”) is an actively managed investment issuer focused on making equity …See details»
Origin Therapeutics | Psychedelic Finance
About Origin Therapeutics Holdings Inc. (CSE: ORIG Proposed) (the “Company” or “Origin Therapeutics”) is an actively managed investment issuer focused on making equity investments in psychedelics-related companies, where legally …See details»
Origin Therapeutics adds Clairvoyant Therapeutics to its Portfolio
Jul 7, 2022 Origin Therapeutics Holdings Inc (the “Company” or “Origin Therapeutics”) is an actively managed investment issuer focused on making equity investments in psychedelics …See details»
Investors - Origin Therapeutics
Investors We provide access to exclusive opportunities Our experienced team of founders, board of directors and management team has access to a diverse deal pipeline and has the requisite …See details»
Origin Therapeutics adds Clairvoyant Therapeutics to its
Jul 7, 2022 According to the World Health Organization, 283 million 1 people aged 15 years and older live with AUD, accounting for 5.1% of the global adult population. Alcohol dependence, …See details»
Origin Therapeutics 2025 Company Profile: Valuation, …
Origin Therapeutics was founded in 2010. Where is Origin Therapeutics headquartered? Origin Therapeutics is headquartered in Vancouver, Canada. What is the size of Origin Therapeutics? Origin Therapeutics has 3 total …See details»
Origin Therapeutics Files Preliminary Prospectus and Announces …
Sep 9, 2021 VANCOUVER, British Columbia, Sept. 09, 2021 (GLOBE NEWSWIRE) — Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”) an actively managed …See details»
Origin Therapeutics (CSE: ORIG) | LinkedIn
Origin Therapeutics (CSE: ORIG) | 209 followers on LinkedIn. A Global Psychedelic-Focused Investment Opportunity | Origin Therapeutics (CSE: ORIG) is an actively-managed investment …See details»
Origin Therapeutics Holdings, Inc. - Drug pipelines, Patents, …
Explore Origin Therapeutics Holdings, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 11 news.See details»
Origin Therapeutics Announces Leadership Team - GlobeNewswire
Nov 16, 2021 Origin Therapeutics Holdings Inc. (CSE: ORIG Proposed) (the “Company” or “Origin Therapeutics”) is an actively managed investment issuer focused on making equity …See details»
Origin Therapeutics Announces New Director - Financial Post
Vancouver, B.C., Sept. 09, 2022 (GLOBE NEWSWIRE) — Origin Therapeutics Holdings Inc. (CSE: ORIG) (the “Company” or “Origin Therapeutics”), an actively managed, psychedelics …See details»
Origin Therapeutics Launches to Fund Emerging Psychedelics
Jul 21, 2021 About Origin Therapeutics. Origin Therapeutics Holdings Inc. (CSE: ORIG Proposed) (the “Company” or “Origin Therapeutics”) is an actively managed investment issuer …See details»
Origin Therapeutics’ Portfolio Company, Clairvoyant, Approved for …
Oct 18, 2022 Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”) is an actively managed investment issuer focused on making equity investments in psychedelics …See details»
Origin Therapeutics to Begin Trading on the CSE Under the
Jun 2, 2022 Origin Therapeutics Holdings Inc (the “Company” or “Origin Therapeutics”) is an actively managed investment issuer focused on making equity investments in psychedelics …See details»
Origen Therapeutics - Crunchbase Company Profile & Funding
Origen Therapeutics, Inc., a biotechnology company, develops products from avian transgenic animal technology. It provides human sequence polyclonal antibodies. The company also …See details»
Origin Therapeutics' Portfolio Company, Clairvoyant, Approved for …
Oct 18, 2022 (the “Company”, “Origin Therapeutics” or “Origin”), an actively managed, psychedelics industry-focused investment issuer, today announced that one of its portfolio …See details»
Dr Nathan Bryan: Innovator in Nitric Oxide Solutions
Nov 14, 2024 Dr Nathan Bryan was the first to describe nitrite and nitrate as indispensable nutrients required for optimal cardiovascular health.He was the first to demonstrate and …See details»
Origin Therapeutics to Begin Trading on the CSE Under the …
Jun 2, 2022 The Company will commence trading on June 6, 2022 under the symbol “ORIG” on the Canadian Securities ExchangeSee details»